Viewing Study NCT00667732


Ignite Creation Date: 2025-12-24 @ 9:48 PM
Ignite Modification Date: 2026-02-26 @ 8:13 PM
Study NCT ID: NCT00667732
Status: COMPLETED
Last Update Posted: 2013-02-06
First Post: 2008-04-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
Sponsor: Oregon Health and Science University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: IND 75,235
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View